By vgreene, 11 March, 2021 KEY FINDINGS early viral clearance observed in ivermectin treated pts vs placebo 5 day course of ivermectin may be safe and effective in mild dz
By vgreene, 11 March, 2021 A Five day Course of Ivermectin for the Treatment of COVID 19 May Reduce the Duration of Illness
By vgreene, 11 March, 2021 Study considerations double blind RCT N 476 primary outcome changed at 6wk younger study population w few comorbidities may have been underpowered to detect smaller reduction in primary end point virological assessments not included ivermectin plasma leve
By vgreene, 11 March, 2021 KEY FINDINGS no significant difference in sx duration in pts w 5 day ivermectin tx vs placebo findings don t support ivermectin tx for mild COVID 19
By vgreene, 11 March, 2021 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID 19 A Randomized Clinical Trial
By vgreene, 11 March, 2021 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID 19 A Randomized Clinical Trial
By vgreene, 11 March, 2021 If pt refuses colonoscopy ACG notes lack of RCTs supporting any screening modality aside from FIT in pts w FHx of CRC1 One RCT compared single colonoscopy w 3 consecutive annual FITs in 1st degree relatives of pts w CRC Advanced neoplasia was detected in
By vgreene, 11 March, 2021 If pt unwilling unable to do colonoscopy or annual FIT ACG1 recommends CT colonography q5y mt sDNA q3y flex sig q5 10y or colon capsule q5y
